CD4 and neoplasm: Moreover, recognition of HLA-DP5+EBNA1+ tumor cells by TCR135-CD4 cells was successfully inhibited by antibody blockade of HLA-DP molecules, indicating that target recognition of TCR135 was HLA-DP restricted (Figure 3E).